Why the study?
Advancements in cardiovascular imaging over the past 14 years rendered the 2005 cirrhotic cardiomyopathy criteria obsolete, necessitating new criteria based on contemporary imaging parameters.
What are the contemporary cardiovascular imaging criteria for diagnosing cirrhotic cardiomyopathy in patients with end-stage liver disease?
What are the contemporary cardiovascular imaging criteria for diagnosing cirrhotic cardiomyopathy in patients with end-stage liver disease?
This guidance document proposes updated diagnostic criteria for cirrhotic cardiomyopathy utilizing modern cardiovascular imaging techniques such as myocardial deformation imaging.
Answers are grounded in this paper and cite their sources.
Standardizes cirrhotic cardiomyopathy diagnosis with modern imaging; replaces 2005 criteria and extends research applications.
Cirrhotic cardiomyopathy (CCM) is cardiac dysfunction in patients with end-stage liver disease in the absence of prior heart disease. First defined in 2005 during the World Congress of Gastroenterology, CCM criteria consisted of echocardiographic parameters to identify subclinical cardiac dysfunction in the absence of overt structural abnormalities. Significant advancements in cardiovascular imaging over the past 14 years, including the integration of myocardial deformation imaging into routine clinical practice to identify subclinical cardiovascular dysfunction, have rendered the 2005 CCM criteria obsolete. Therefore, new criteria based on contemporary cardiovascular imaging parameters are needed. In this guidance document, assembled by a group of multidisciplinary experts in the field, new core criteria based on contemporary cardiovascular imaging parameters are proposed for the assessment of CCM. This document provides a critical assessment of the diagnosis of CCM and ongoing assessment aimed at improving clinical outcomes, particularly surrounding liver transplantation. Key points and practice-based recommendations for the diagnosis of CCM are provided to offer guidance for clinicians and identify gaps in knowledge for future investigations.
No takes yet. Share an insight, caveat, or question.
Izzy et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: